Amy Simon
About Amy Simon
Amy Simon, M.D., is the Chief Medical Officer with a distinguished background in clinical development and medical education, known for leading the FDA-approved clinical development of GIVLAARI at Alnylam Pharmaceuticals.
Amy Simon, M.D. Chief Medical Officer
Amy Simon, M.D. currently serves as the Chief Medical Officer. She plays a crucial role in overseeing medical and clinical operations within the organization. Dr. Simon brings a wealth of experience from her extensive medical and professional background, significantly contributing to strategic leadership and clinical development efforts.
Education and Medical Expertise of Amy Simon, M.D.
Amy Simon holds a B.A. in History and Science from Harvard University. She then pursued her medical degree at Tufts University School of Medicine. Dr. Simon has undergone rigorous medical training, including a residency in internal medicine and a fellowship in pulmonary and critical care medicine at Tufts Medical Center. Her educational background and expertise have been pivotal in her professional achievements and leadership roles.
Professional Background and Experience of Amy Simon, M.D.
Dr. Amy Simon has built a distinguished career in the medical field. She worked at Alnylam Pharmaceuticals for over a decade, culminating in her role as Vice President, Clinical Development. During her tenure, she led the clinical development of GIVLAARI (givosiran) for acute hepatic porphyria, a treatment that gained FDA approval in 2019. Additionally, Dr. Simon has experience in clinical practice and conducting groundbreaking research, particularly in asthma.
Academic Contributions of Amy Simon, M.D.
In academia, Dr. Amy Simon has served as a professor and director of the Asthma Center within the Pulmonary and Critical Care Division at Tufts University School of Medicine. She was also a professor at Tufts Graduate School of Biomedical Sciences. Dr. Simon's academic roles have involved basic science research on asthma, contributing to medical knowledge and advancing the field through her laboratory work.